Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy

Affiliations

• ¹ Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
• ² Oxford University Hospitals, NHS Foundation Trust, Oxford, UK.
• ³ Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.
• ⁴ Gilead Sciences, Inc, Foster City, California, USA.
• ⁵ New York Blood Center Enterprises, Immunohematology and Blood Group Genomics, New York, New York, USA.
• ⁶ NHS Blood and Transplant, Oxford University Hospitals NHS Foundation Trust and the University of Oxford, Oxford, UK.